Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein

Journal of Biotechnology

Volumn 111, Issue 1, 2004, Pages 97-104

  Luo, Dong ^a   Rogers, Chad N ^a   Steed, Jordan T ^a   Gilliam, Lisa K ^a   Hampe, Christiane S ^a   Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibody binding assays; Biotin GAD65; Type 1 diabetes

Indexed keywords

BIOASSAY; IMMUNOLOGY; ORGANIC ACIDS; PATIENT MONITORING; PROTEINS;

COEFFICIENT OF VARIATION (COV); RADIOIMMUNOASSAYS (RIA);

BIOTECHNOLOGY;

BIOTIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE ANTIBODY; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCUBATION TIME; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AUTOANTIGENS; BIOLOGICAL MARKERS; BIOTIN; BLOOD CHEMICAL ANALYSIS; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAMATE DECARBOXYLASE; HUMANS; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 2942519371     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2004.03.009     Document Type: Article

References (29)

1. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 298:1982;167-169
2. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156
3. Barker D.F., Campbell A.M. The birA gene of Escherichia coli encodes a biotin holoenzyme synthetase. J. Mol. Biol. 146:1981a;451-467
4. Barker D.F., Campbell A.M. Genetic and biochemical characterization of the birA gene and its product: evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli. J. Mol. Biol. 146:1981b;469-492
5. Beckett D., Kovaleva E., Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8:1999;921-929
6. Cook A. An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr. Top. Microbiol. Immunol. 164:1990;125-135
7. Falorni A., Ortqvist E., Persson B., Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J. Immunol. Methods. 186:1995;89-99
8. Falorni A., Ackefors M., Carlberg C., Daniels T., Persson B., Robertson J., Lernmark Å. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia. 39:1996;1091-1098
9. Gitlin G., Bayer E.A., Wilchek M. Studies on the biotin-binding sites of avidin and streptavidin. Tyrosine residues are involved in the binding site. Biochem. J. 269:1990;527-530
10. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark Å. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:1994;344-350
11. Hampe C.S., Hammerle L.P., Bekris L., Ortqvist E., Kockum I., Rolandsson O., Landin-Olsson M., Torn C., Persson B., Lernmark Å. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J. Clin. Endocrinol. Metab. 85:2000;4671-4679
12. Hampe C.S., Lundgren P., Daniels T.L., Hammerle L.P., Marcovina S.M., Lernmark Å. A novel monoclonal antibody specific for the N-terminal end of GAD65. J. Neuroimmunol. 113:2001;63-71
13. Hjelm H., Sjodahl J., Sjoquist J. Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus. Eur. J. Biochem. 57:1975;395-403
14. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., Adler D.A., Barmeier H., Mathewes S., Grant F.J., Foster D., Lernmark Å. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8337-8341
15. Karlsen A.E., Hagopian W.A., Petersen J.S., Boel E., Dyrberg T., Grubin C.E., Michelsen B.K., Madsen O.D., Lernmark Å. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64, 000-M(r) autoantibodies. Diabetes. 41:1992;1355-1359
16. Landin-Olsson M., Arnqvist H.J., Blohme G., Littorin B., Lithner F., Nystrom L., Schersten B., Sundkvist G., Wibell L., Ostman J., Lernmark Å. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity. 29:1999;57-63
17. Ludvigsson J., Heding L., Liedèn G., Marner B., Lernmark Å. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br. Med. J. 286:1983;176-178
18. Luo D., Rogers C.N., Hampe C.S., Lernmark Å. Molecular enginering of biotin-glutamic acid decarboxylase 65 fusion protein (biotin-GAF65) for non-radioactive GAD65 antibody assay. J. Biotechnol. 103:2003;249-255
19. Marner B., Lernmark Å., Ludvigsson J., MacKay P., Matsuba I., Nerup J., Rabinovitch A. Islet cell antibodies in insulin-dependent (Type 1) diabetic children treated with plasmapheresis. Diabetes Res. 2:1985;231-236
20. Mire-Sluis A.R., Das R.G., Lernmark Å. The development of a World Health Organisation international standard for islet cell antibodies: the aims and design of an international collaborative study. Diabetes Metab. Res. Rev. 15:1999;72-77
21. Mire-Sluis A.R., Gaines Das R., Lernmark Å. The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia. 43:2000;1282-1292
22. Olsson M.L., Sundkvist G., Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 30:1987;327-332
23. Rabinovitch A., MacKay P., Ludvigsson J., Lernmark Å. A prospective analysis of islet cell cytotoxic antibodies in insulin-dependent diabetic children: Transient effects of plasmapheresis. Diabetes. 33:1984;224-228
24. Richter W., Shi Y., Baekkeskov S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2832-2836
25. Samols D., Thornton C.G., Murtif V.L., Kumar G.K., Haase F.C., Wood H.G. Evolutionary conservation among biotin enzymes. J. Biol. Chem. 263:1988;6461-6464
26. Schranz D.B., Bekris L., Landin-Olsson M., Torn C., Nilang A., Toll A., Sjostrom J., Gronlund H., Lernmark Å. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS). Horm. Metab. Res. 32:2000;133-138
27. Torn C., Landin-Olsson M., Ostman J., Schersten B., Arnqvist H., Blohme G., Bjork E., Bolinder J., Eriksson J., Littorin B., Nystrom L., Sundkvist G., Lernmark Å. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type 1 diabetes on clinical grounds. Diabetes Metab. Res. Rev. 16:2000;442-447
28. Tuomi T., Rowley M.J., Knowles W.J., Chen Q.Y., McAnally T., Zimmet P.Z., Mackay I.R. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 71:1994;53-59
29. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 45:1996;926-933